Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia

Clinical trial NCT05388123 · COMPLETED

Trial details

NCT number: NCT05388123
Sponsor: Scripps Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hairy Cell Leukemia

Start date: 2022-03-02
Primary completion: 2026-04-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.